Trevi Therapeutics, Inc.
Ticker: TRVI
| Insider | Title |
|---|---|
| 16 Gp, Llc Nea | 10% or greater ownership |
| Ali Behbahani | 10% or greater ownership |
| Anne Vanlent | Director |
| Anthony A. Jr. Florence | 10% or greater ownership |
| Carmen Chang | 10% or greater ownership |
| Christopher Galletta | See Remarks |
| David Bonderman | Former 10% Owner |
| David J Clark | Chief Medical Officer |
| David P Meeker | Director |
| Dominick Colangelo | Director |
| Edward T Mathers | Director |
| Enterprise Associates 16, L.p. New | 10% or greater ownership |
| Farrell Simon | Chief Commercial Officer |
| Forest Baskett | 10% or greater ownership |
| Gp A, Llc Tpg | Former 10% Owner |
| James G Coulter | Former 10% Owner |
| James V Cassella | Chief Development Officer |
| Jennifer L Good | President CEO, Director |
| Jon Winkelried | Former 10% Owner |
| Lisa Delfini | Chief Financial Officer |
| Michael Thomas Heffernan | Director |
| Mohamad Makhzoumi | 10% or greater ownership |
| Partners 16, L.p. Nea | 10% or greater ownership |
| Paul Edward Walker | 10% or greater ownership |
| Peter W. Sonsini | 10% or greater ownership |
| Scott D Sandell | 10% or greater ownership |
| Thomas Sciascia | Chief Scientific Officer |
| William P Forbes | Chief Development Officer |